Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
MedPlus Health Services informed exchanges that its subsidiary Optival Health Solutions received a one-day suspension order on the Drug License for a store located on Kalsapur Road, Gadag, Karnataka. The order was issued by the Assistant Director, Drugs Control Administration, Bangalore Circle-Gadag, under Rule 65 of the Drugs and Cosmetics Act, 1940, and was received on July 28, 2025. The company estimates a potential revenue loss of about Rs 0.21 lakh (roughly Rs 21,000) for the affected day. Only a single store is impacted, and the license suspension is for just one day. Optival Health Solutions is the subsidiary through which MedPlus operates its pharmacy retail business.
The financial impact is negligible (around Rs 21,000), and only one store is affected for a single day, so this is unlikely to have any meaningful effect on the stock price or overall business operations. Investors should treat this as a routine regulatory compliance matter with no material bearing on the company's earnings.